scispace - formally typeset
Search or ask a question
Author

Javier Costas

Bio: Javier Costas is an academic researcher from University of Santiago de Compostela. The author has contributed to research in topics: Single-nucleotide polymorphism & Genome-wide association study. The author has an hindex of 28, co-authored 84 publications receiving 5288 citations. Previous affiliations of Javier Costas include University of Santiago, Chile & Instituto de Biologia Molecular e Celular.


Papers
More filters
Journal ArticleDOI
Hreinn Stefansson1, Hreinn Stefansson2, Roel A. Ophoff3, Roel A. Ophoff4, Roel A. Ophoff2, Stacy Steinberg1, Stacy Steinberg2, Ole A. Andreassen5, Sven Cichon6, Dan Rujescu7, Thomas Werge8, Olli Pietilainen9, Ole Mors10, Preben Bo Mortensen11, Engilbert Sigurdsson12, Omar Gustafsson1, Mette Nyegaard11, Annamari Tuulio-Henriksson13, Andres Ingason1, Thomas Hansen8, Jaana Suvisaari13, Jouko Lönnqvist13, Tiina Paunio, Anders D. Børglum10, Anders D. Børglum11, Annette M. Hartmann7, Anders Fink-Jensen8, Merete Nordentoft14, David M. Hougaard, Bent Nørgaard-Pedersen, Yvonne Böttcher1, Jes Olesen15, René Breuer16, Hans-Jürgen Möller7, Ina Giegling7, Henrik B. Rasmussen8, Sally Timm8, Manuel Mattheisen6, István Bitter17, János Réthelyi17, Brynja B. Magnusdottir12, Thordur Sigmundsson12, Pall I. Olason1, Gisli Masson1, Jeffrey R. Gulcher1, Magnús Haraldsson12, Ragnheidur Fossdal1, Thorgeir E. Thorgeirsson1, Unnur Thorsteinsdottir1, Unnur Thorsteinsdottir12, Mirella Ruggeri18, Sarah Tosato18, Barbara Franke19, Eric Strengman4, Lambertus A. Kiemeney19, Ingrid Melle5, Srdjan Djurovic5, Lilia I. Abramova20, Kaleda Vg20, Julio Sanjuán21, Rosa de Frutos21, Elvira Bramon22, Evangelos Vassos22, Gillian Fraser23, Ulrich Ettinger22, Marco Picchioni22, Nicholas Walker, T. Toulopoulou22, Anna C. Need24, Dongliang Ge24, Joeng Lim Yoon3, Kevin V. Shianna24, Nelson B. Freimer3, Rita M. Cantor3, Robin M. Murray22, Augustine Kong1, Vera Golimbet20, Angel Carracedo25, Celso Arango26, Javier Costas, Erik G. Jönsson27, Lars Terenius27, Ingrid Agartz27, Hannes Petursson12, Markus M. Nöthen6, Marcella Rietschel16, Paul M. Matthews28, Pierandrea Muglia29, Leena Peltonen9, David St Clair23, David Goldstein24, Kari Stefansson12, Kari Stefansson1, David A. Collier30, David A. Collier22 
06 Aug 2009-Nature
TL;DR: Findings implicating the MHC region are consistent with an immune component to schizophrenia risk, whereas the association with NRGN and TCF4 points to perturbation of pathways involved in brain development, memory and cognition.
Abstract: Schizophrenia is a complex disorder, caused by both genetic and environmental factors and their interactions. Research on pathogenesis has traditionally focused on neurotransmitter systems in the brain, particularly those involving dopamine. Schizophrenia has been considered a separate disease for over a century, but in the absence of clear biological markers, diagnosis has historically been based on signs and symptoms. A fundamental message emerging from genome-wide association studies of copy number variations (CNVs) associated with the disease is that its genetic basis does not necessarily conform to classical nosological disease boundaries. Certain CNVs confer not only high relative risk of schizophrenia but also of other psychiatric disorders. The structural variations associated with schizophrenia can involve several genes and the phenotypic syndromes, or the 'genomic disorders', have not yet been characterized. Single nucleotide polymorphism (SNP)-based genome-wide association studies with the potential to implicate individual genes in complex diseases may reveal underlying biological pathways. Here we combined SNP data from several large genome-wide scans and followed up the most significant association signals. We found significant association with several markers spanning the major histocompatibility complex (MHC) region on chromosome 6p21.3-22.1, a marker located upstream of the neurogranin gene (NRGN) on 11q24.2 and a marker in intron four of transcription factor 4 (TCF4) on 18q21.2. Our findings implicating the MHC region are consistent with an immune component to schizophrenia risk, whereas the association with NRGN and TCF4 points to perturbation of pathways involved in brain development, memory and cognition.

1,625 citations

Journal ArticleDOI
Vishvanath Nene1, Jennifer R. Wortman1, Daniel Lawson, Brian J. Haas1, Chinnappa D. Kodira2, Zhijian Jake Tu3, Brendan J. Loftus, Zhiyong Xi4, Karyn Megy, Manfred Grabherr2, Quinghu Ren1, Evgeny M. Zdobnov, Neil F. Lobo5, Kathryn S. Campbell6, Susan E. Brown7, Maria de Fatima Bonaldo8, Jingsong Zhu9, Steven P. Sinkins10, David G. Hogenkamp11, Paolo Amedeo1, Peter Arensburger9, Peter W. Atkinson9, Shelby L. Bidwell1, Jim Biedler3, Ewan Birney, Robert V. Bruggner5, Javier Costas, Monique R. Coy3, Jonathan Crabtree1, Matt Crawford2, Becky deBruyn5, David DeCaprio2, Karin Eiglmeier12, Eric Eisenstadt1, Hamza El-Dorry13, William M. Gelbart6, Suely Lopes Gomes13, Martin Hammond, Linda Hannick1, James R. Hogan5, Michael H. Holmes1, David M. Jaffe2, J. Spencer Johnston, Ryan C. Kennedy5, Hean Koo1, Saul A. Kravitz, Evgenia V. Kriventseva14, David Kulp15, Kurt LaButti2, Eduardo Lee1, Song Li3, Diane D. Lovin5, Chunhong Mao3, Evan Mauceli2, Carlos Frederico Martins Menck13, Jason R. Miller1, Philip Montgomery2, Akio Mori5, Ana L. T. O. Nascimento16, Horacio Naveira17, Chad Nusbaum2, Sinéad B. O'Leary2, Joshua Orvis1, Mihaela Pertea, Hadi Quesneville, Kyanne R. Reidenbach11, Yu-Hui Rogers, Charles Roth12, Jennifer R. Schneider5, Michael C. Schatz, Martin Shumway1, Mario Stanke, Eric O. Stinson5, Jose M. C. Tubio, Janice P. Vanzee11, Sergio Verjovski-Almeida13, Doreen Werner18, Owen White1, Stefan Wyder14, Qiandong Zeng2, Qi Zhao1, Yongmei Zhao1, Catherine A. Hill11, Alexander S. Raikhel9, Marcelo B. Soares8, Dennis L. Knudson7, Norman H. Lee, James E. Galagan2, Steven L. Salzberg, Ian T. Paulsen1, George Dimopoulos4, Frank H. Collins5, Bruce W. Birren2, Claire M. Fraser-Liggett, David W. Severson5 
22 Jun 2007-Science
TL;DR: A draft sequence of the genome of Aedes aegypti, the primary vector for yellow fever and dengue fever, which at approximately 1376 million base pairs is about 5 times the size of the genomes of the malaria vector Anopheles gambiae was presented in this paper.
Abstract: We present a draft sequence of the genome of Aedes aegypti, the primary vector for yellow fever and dengue fever, which at approximately 1376 million base pairs is about 5 times the size of the genome of the malaria vector Anopheles gambiae. Nearly 50% of the Ae. aegypti genome consists of transposable elements. These contribute to a factor of approximately 4 to 6 increase in average gene length and in sizes of intergenic regions relative to An. gambiae and Drosophila melanogaster. Nonetheless, chromosomal synteny is generally maintained among all three insects, although conservation of orthologous gene order is higher (by a factor of approximately 2) between the mosquito species than between either of them and the fruit fly. An increase in genes encoding odorant binding, cytochrome P450, and cuticle domains relative to An. gambiae suggests that members of these protein families underpin some of the biological differences between the two mosquito species.

1,107 citations

Journal ArticleDOI
TL;DR: In this article , a two-stage genome-wide association study of up to 76,755 individuals with schizophrenia and 243,649 control individuals was conducted, and the authors reported common variant associations at 287 distinct genomic loci.
Abstract: Schizophrenia has a heritability of 60–80%1, much of which is attributable to common risk alleles. Here, in a two-stage genome-wide association study of up to 76,755 individuals with schizophrenia and 243,649 control individuals, we report common variant associations at 287 distinct genomic loci. Associations were concentrated in genes that are expressed in excitatory and inhibitory neurons of the central nervous system, but not in other tissues or cell types. Using fine-mapping and functional genomic data, we identify 120 genes (106 protein-coding) that are likely to underpin associations at some of these loci, including 16 genes with credible causal non-synonymous or untranslated region variation. We also implicate fundamental processes related to neuronal function, including synaptic organization, differentiation and transmission. Fine-mapped candidates were enriched for genes associated with rare disruptive coding variants in people with schizophrenia, including the glutamate receptor subunit GRIN2A and transcription factor SP4, and were also enriched for genes implicated by such variants in neurodevelopmental disorders. We identify biological processes relevant to schizophrenia pathophysiology; show convergence of common and rare variant associations in schizophrenia and neurodevelopmental disorders; and provide a resource of prioritized genes and variants to advance mechanistic studies. A genome-wide association study including over 76,000 individuals with schizophrenia and over 243,000 control individuals identifies common variant associations at 287 genomic loci, and further fine-mapping analyses highlight the importance of genes involved in synaptic processes.

558 citations

Journal ArticleDOI
Marta Di Forti1, Marta Di Forti2, Marta Di Forti3, Diego Quattrone2, Diego Quattrone3, Diego Quattrone1, Tom P. Freeman4, Giada Tripoli2, Charlotte Gayer-Anderson2, Harriet Quigley2, Victoria Rodriguez2, Hannah E Jongsma5, Hannah E Jongsma6, Laura Ferraro7, Caterina La Cascia7, Daniele La Barbera7, Ilaria Tarricone8, Domenico Berardi8, Andrei Szöke9, Celso Arango10, Andrea Tortelli, Eva Velthorst11, Miguel Bernardo12, Cristina Marta Del-Ben13, Paulo Rossi Menezes13, Jean-Paul Selten, Peter B. Jones5, James B. Kirkbride6, Bart P. F. Rutten14, Lieuwe de Haan11, Pak C. Sham15, Pak C. Sham2, Jim van Os2, Jim van Os16, Cathryn M. Lewis2, Cathryn M. Lewis1, Michael T. Lynskey2, Craig Morgan2, Robin M. Murray2, Robin M. Murray3, Silvia Amoretti, Manuel Arrojo, Grégoire Baudin, Stephanie Beards, Miquel Bernardo12, Julio Bobes, Chiara Bonetto, Bibiana Cabrera, Angel Carracedo, Thomas Charpeaud, Javier Costas, Doriana Cristofalo, Pedro Cuadrado, Covadonga M. Díaz-Caneja, Aziz Ferchiou, Nathalie Franke, Flora Frijda, Enrique García Bernardo, Paz García-Portilla, Emiliano González, Kathryn Hubbard, Stéphane Jamain, Estela Jiménez-López, Marion Leboyer, Gonzalo López Montoya, Esther Lorente-Rovira, Camila Marcelino Loureiro, Giovanna Marrazzo, Covadonga Martínez, Mario de Matteis, Elles Messchaart, Ma Dolores Moltó, Juan Nacher, Ma Soledad Olmeda, Mara Parellada, Javier González Peñas, Baptiste Pignon, Marta Rapado, Jean Romain Richard, José Juan Rodríguez Solano, Laura Roldán Díaz, Mirella Ruggeri, Pilar A. Saiz, Emilio Sánchez, Julio Sanjuán, Crocettarachele Sartorio, Franck Schürhoff, F. Seminerio, Rosana Shuhama, Lucia Sideli, Simona A. Stilo, Fabian Termorshuizen, Sarah Tosato, Anne Marie Tronche, Daniella van Dam, Elsje van der Ven 
TL;DR: Differences in frequency of daily cannabis use and in use of high-potency cannabis contributed to the striking variation in the incidence of psychotic disorder across the 11 studied sites, giving important implications for public health.

496 citations

Journal ArticleDOI
Peter Arensburger1, Karyn Megy, Robert M. Waterhouse2, Robert M. Waterhouse3, Jenica L. Abrudan4, Paolo Amedeo5, Beatriz García Antelo6, Lyric C. Bartholomay7, Shelby L. Bidwell, Elisabet Caler5, Francisco Camara, Corey L. Campbell8, Kathryn S. Campbell9, Claudio Casola10, Marta T Castro11, Ishwar Chandramouliswaran5, Sinéad B. Chapman12, Scott Christley4, Javier Costas, Eric Eisenstadt5, Cédric Feschotte13, Claire M. Fraser-Liggett14, Roderic Guigó, Brian J. Haas12, Martin Hammond, Bill S. Hansson15, Janet Hemingway16, Sharon R. Hill17, Clint Howarth12, Rickard Ignell17, Ryan C. Kennedy4, Chinnappa D. Kodira18, Neil F. Lobo4, Chunhong Mao19, George F. Mayhew20, Kristin Michel21, Akio Mori4, Nannan Liu22, Horacio Naveira23, Vishvanath Nene24, Vishvanath Nene14, Nam P. Nguyen13, Matthew D. Pearson12, Ellen J. Pritham13, Daniela Puiu25, Yumin Qi19, Hilary Ranson16, José M. C. Ribeiro26, Hugh M Roberston27, David W. Severson4, Martin Shumway26, Mario Stanke28, Robert L. Strausberg5, Cheng Sun13, Granger G. Sutton5, Zhijian Jake Tu19, Jose M. C. Tubio6, Maria F. Unger4, Dana L. Vanlandingham29, Albert J. Vilella, Owen White14, Jared White12, Charles S. Wondji16, Jennifer R. Wortman14, Evgeny M. Zdobnov29, Evgeny M. Zdobnov3, Evgeny M. Zdobnov2, Bruce W. Birren12, Bruce M. Christensen20, Frank H. Collins4, Anthony J. Cornel30, George Dimopoulos31, Linda Hannick5, Stephen Higgs29, Gregory C. Lanzaro32, Daniel Lawson, Norman H. Lee33, Marc A. T. Muskavitch9, Marc A. T. Muskavitch34, Marc A. T. Muskavitch12, Alexander S. Raikhel1, Peter W. Atkinson1 
01 Oct 2010-Science
TL;DR: The genomic sequence of C. quinquefasciatus is described, which reveals distinctions related to vector capacities and habitat preferences, and confirmed that inoculation with unfamiliar bacteria prompted strong immune responses in Culex.
Abstract: Culex quinquefasciatus (the southern house mosquito) is an important mosquito vector of viruses such as West Nile virus and St. Louis encephalitis virus, as well as of nematodes that cause lymphatic filariasis. C. quinquefasciatus is one species within the Culex pipiens species complex and can be found throughout tropical and temperate climates of the world. The ability of C. quinquefasciatus to take blood meals from birds, livestock, and humans contributes to its ability to vector pathogens between species. Here, we describe the genomic sequence of C. quinquefasciatus: Its repertoire of 18,883 protein-coding genes is 22% larger than that of Aedes aegypti and 52% larger than that of Anopheles gambiae with multiple gene-family expansions, including olfactory and gustatory receptors, salivary gland genes, and genes associated with xenobiotic detoxification.

452 citations


Cited by
More filters
Journal ArticleDOI
Stephan Ripke1, Stephan Ripke2, Benjamin M. Neale2, Benjamin M. Neale1  +351 moreInstitutions (102)
24 Jul 2014-Nature
TL;DR: Associations at DRD2 and several genes involved in glutamatergic neurotransmission highlight molecules of known and potential therapeutic relevance to schizophrenia, and are consistent with leading pathophysiological hypotheses.
Abstract: Schizophrenia is a highly heritable disorder. Genetic risk is conferred by a large number of alleles, including common alleles of small effect that might be detected by genome-wide association studies. Here we report a multi-stage schizophrenia genome-wide association study of up to 36,989 cases and 113,075 controls. We identify 128 independent associations spanning 108 conservatively defined loci that meet genome-wide significance, 83 of which have not been previously reported. Associations were enriched among genes expressed in brain, providing biological plausibility for the findings. Many findings have the potential to provide entirely new insights into aetiology, but associations at DRD2 and several genes involved in glutamatergic neurotransmission highlight molecules of known and potential therapeutic relevance to schizophrenia, and are consistent with leading pathophysiological hypotheses. Independent of genes expressed in brain, associations were enriched among genes expressed in tissues that have important roles in immunity, providing support for the speculated link between the immune system and schizophrenia.

6,809 citations

Journal ArticleDOI
Shaun Purcell1, Shaun Purcell2, Naomi R. Wray3, Jennifer Stone2, Jennifer Stone1, Peter M. Visscher, Michael Conlon O'Donovan4, Patrick F. Sullivan5, Pamela Sklar1, Pamela Sklar2, Douglas M. Ruderfer, Andrew McQuillin, Derek W. Morris6, Colm O'Dushlaine6, Aiden Corvin6, Peter Holmans4, Stuart MacGregor3, Hugh Gurling, Douglas Blackwood7, Nicholas John Craddock5, Michael Gill6, Christina M. Hultman8, Christina M. Hultman9, George Kirov4, Paul Lichtenstein9, Walter J. Muir7, Michael John Owen4, Carlos N. Pato10, Edward M. Scolnick1, Edward M. Scolnick2, David St Clair, Nigel Williams4, Lyudmila Georgieva4, Ivan Nikolov4, Nadine Norton4, Hywel Williams4, Draga Toncheva, Vihra Milanova, Emma Flordal Thelander9, Patrick Sullivan11, Elaine Kenny6, Emma M. Quinn6, Khalid Choudhury12, Susmita Datta12, Jonathan Pimm12, Srinivasa Thirumalai13, Vinay Puri12, Robert Krasucki12, Jacob Lawrence12, Digby Quested14, Nicholas Bass12, Caroline Crombie15, Gillian Fraser15, Soh Leh Kuan, Nicholas Walker, Kevin A. McGhee7, Ben S. Pickard16, P. Malloy7, Alan W Maclean7, Margaret Van Beck7, Michele T. Pato10, Helena Medeiros10, Frank A. Middleton17, Célia Barreto Carvalho10, Christopher P. Morley17, Ayman H. Fanous, David V. Conti10, James A. Knowles10, Carlos Ferreira, António Macedo18, M. Helena Azevedo18, Andrew Kirby2, Andrew Kirby1, Manuel A. R. Ferreira2, Manuel A. R. Ferreira1, Mark J. Daly1, Mark J. Daly2, Kimberly Chambert1, Finny G Kuruvilla1, Stacey Gabriel1, Kristin G. Ardlie1, Jennifer L. Moran1 
06 Aug 2009-Nature
TL;DR: The extent to which common genetic variation underlies the risk of schizophrenia is shown, using two analytic approaches, and the major histocompatibility complex is implicate, which is shown to involve thousands of common alleles of very small effect.
Abstract: Schizophrenia is a severe mental disorder with a lifetime risk of about 1%, characterized by hallucinations, delusions and cognitive deficits, with heritability estimated at up to 80%(1,2). We performed a genome-wide association study of 3,322 European individuals with schizophrenia and 3,587 controls. Here we show, using two analytic approaches, the extent to which common genetic variation underlies the risk of schizophrenia. First, we implicate the major histocompatibility complex. Second, we provide molecular genetic evidence for a substantial polygenic component to the risk of schizophrenia involving thousands of common alleles of very small effect. We show that this component also contributes to the risk of bipolar disorder, but not to several non-psychiatric diseases.

4,573 citations

01 Feb 2015
TL;DR: In this article, the authors describe the integrative analysis of 111 reference human epigenomes generated as part of the NIH Roadmap Epigenomics Consortium, profiled for histone modification patterns, DNA accessibility, DNA methylation and RNA expression.
Abstract: The reference human genome sequence set the stage for studies of genetic variation and its association with human disease, but epigenomic studies lack a similar reference. To address this need, the NIH Roadmap Epigenomics Consortium generated the largest collection so far of human epigenomes for primary cells and tissues. Here we describe the integrative analysis of 111 reference human epigenomes generated as part of the programme, profiled for histone modification patterns, DNA accessibility, DNA methylation and RNA expression. We establish global maps of regulatory elements, define regulatory modules of coordinated activity, and their likely activators and repressors. We show that disease- and trait-associated genetic variants are enriched in tissue-specific epigenomic marks, revealing biologically relevant cell types for diverse human traits, and providing a resource for interpreting the molecular basis of human disease. Our results demonstrate the central role of epigenomic information for understanding gene regulation, cellular differentiation and human disease.

4,409 citations

Journal ArticleDOI
TL;DR: In this article, an automated eukaryotic gene structure annotation tool, EVM, is presented as a weighted consensus of all available evidence, combined with the Program to Assemble Spliced Alignments (PASA), yields a comprehensive, configurable annotation system that predicts protein coding genes and alternatively spliced isoforms.
Abstract: EVidenceModeler (EVM) is presented as an automated eukaryotic gene structure annotation tool that reports eukaryotic gene structures as a weighted consensus of all available evidence. EVM, when combined with the Program to Assemble Spliced Alignments (PASA), yields a comprehensive, configurable annotation system that predicts protein-coding genes and alternatively spliced isoforms. Our experiments on both rice and human genome sequences demonstrate that EVM produces automated gene structure annotation approaching the quality of manual curation.

1,996 citations